Label: DPC PINK AURA CUSHION NO.23- titanium dioxide, ethylhexyl methoxycinnamate, ethylhexyl salicylate, isoamyl p-methoxycinnamate, niacinamide, bis-ethylhexyloxyphenol methoxyphenyl triazine, adenosine liquid

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph not final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated August 24, 2017

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    Titanium Dioxide, Ethylhexyl Methoxycinnamate, Ethylhexyl Salicylate, Isoamyl p-Methoxycinnamate, Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine, Adenosine

  • INACTIVE INGREDIENT

    Water, Butylene Glycol, etc.

  • PURPOSE

    Sun block, Skin whitening, Wrinkle reducer

  • KEEP OUT OF REACH OF CHILDREN

    keep out or reach of the children

  • INDICATIONS & USAGE

    Take the puff and press it into the cushion, then tap it all round your face to spread it evenly on your face.

  • WARNINGS

    For external use only.
    Avoid contact with eyes. Not for human consumption.
    Discontinue use if irritation occurs.
    If irritation persists, consult a physician.
    Please close the lid after use. If not, useful moisurizing and other contents can vaporize and the content can be ruduced.

  • DOSAGE & ADMINISTRATION

    for external use only


  • PRINCIPAL DISPLAY PANEL

    1

  • INGREDIENTS AND APPEARANCE
    DPC PINK AURA CUSHION NO.23 
    titanium dioxide, ethylhexyl methoxycinnamate, ethylhexyl salicylate, isoamyl p-methoxycinnamate, niacinamide, bis-ethylhexyloxyphenol methoxyphenyl triazine, adenosine liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:71673-0008
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE7 g  in 100 g
    AMILOXATE (UNII: 376KTP06K8) (AMILOXATE - UNII:376KTP06K8) AMILOXATE3 g  in 100 g
    OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE3 g  in 100 g
    BEMOTRIZINOL (UNII: PWZ1720CBH) (BEMOTRIZINOL - UNII:PWZ1720CBH) BEMOTRIZINOL1.5 g  in 100 g
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE12.7 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:71673-0008-115 g in 1 CONTAINER; Type 0: Not a Combination Product07/01/2017
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph not finalpart35207/01/2017
    Labeler - MSCO (689039838)
    Registrant - MSCO (689039838)
    Establishment
    NameAddressID/FEIBusiness Operations
    MSCO689039838label(71673-0008)
    Establishment
    NameAddressID/FEIBusiness Operations
    Cit Co., Ltd690081646manufacture(71673-0008)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!